Back to search
FDAFDA · Food and drugs·Recall number D-0605-2018

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

Published April 4, 2018 · Recall initiated: March 2, 2018

Summary

FDA records drug Class III recall D-0605-2018, published April 4, 2018 and initiated March 2, 2018. Recalling firm: Renaissance Lakewood, LLC; Status: Terminated; Reported quantity: 1277 bags; Lot: Lot A060644, May 2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Renaissance Lakewood, LLC
Distributor
Nationwide
Lot
Lot A060644, May 2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10 recalled?

Yes. FDA published recall D-0605-2018 on April 4, 2018. Reported hazard: Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability

What should I do if I have this product?

Voluntary: Firm initiated · Letter